Responses
Cardiovascular medicine
Protocol
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
Compose a Response to This Article
Other responses
No responses have been published for this article.